Cargando…
Genetic Polymorphisms Affecting Ranibizumab Response in High Myopia Patients
High myopia is an ophthalmic pathology that affects half of the young adults in the United States and Europe and it is predicted that a third of the world’s population could be nearsighted at the end of this decade. It is characterized by at least 6 diopters or axial length > 26 mm and, choroidal...
Autores principales: | Blánquez-Martínez, David, Díaz-Villamarín, Xando, Antúnez-Rodríguez, Alba, Pozo-Agundo, Ana, Muñoz-Ávila, José Ignacio, Martínez-González, Luis Javier, Dávila-Fajardo, Cristina Lucía |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8620862/ https://www.ncbi.nlm.nih.gov/pubmed/34834388 http://dx.doi.org/10.3390/pharmaceutics13111973 |
Ejemplares similares
-
Genetic Polymorphisms in VEGFR Coding Genes (FLT1/KDR) on Ranibizumab Response in High Myopia and Choroidal Neovascularization Patients
por: Blánquez-Martínez, David, et al.
Publicado: (2022) -
Genetic Variants Affecting Anti-VEGF Drug Response in Polypoidal Choroidal Vasculopathy Patients: A Systematic Review and Meta-Analysis
por: Díaz-Villamarín, Xando, et al.
Publicado: (2020) -
Pharmacogenetics in the Treatment of Cardiovascular Diseases and Its Current Progress Regarding Implementation in the Clinical Routine
por: Dávila-Fajardo, Cristina Lucía, et al.
Publicado: (2019) -
A New Pharmacogenetic Algorithm to Predict the Most Appropriate Dosage of Acenocoumarol for Stable Anticoagulation in a Mixed Spanish Population
por: Tong, Hoi Y., et al.
Publicado: (2016) -
Economic evaluation of pharmacogenomic-guided antiplatelet treatment in Spanish patients suffering from acute coronary syndrome participating in the U-PGx PREPARE study
por: Koufaki, Margarita-Ioanna, et al.
Publicado: (2023)